Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,583.81
(
-0.62%
)
US TECH 100
23,572.80
(
-0.94%
)
Dow Jones
45,842.84
(
-0.83%
)
Brent Oil
107.12
(
0.51%
)
Bitcoin
69,476.47
(
-2.48%
)
News Focus
News Focus
Post# of 257259
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

NP1986

Send PM Follow Ignore
Followers 6
Posts 541
Boards Moderated 0
Alias Born 06/07/2011

NP1986

Re: biomaven0 post# 121233

Tuesday, 06/07/2011 10:01:27 PM

Tuesday, June 07, 2011 10:01:27 PM

Post# of 257259
If that's the case, then it bodes well for ALK inhibitors. But I'm always weary of "a sure thing" as far as cancer cells are concerned. Even if EML4-ALK is an oncogenic driver, it doesn't preclude other pathways from being upregulated/downregulated in these cells.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now